Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Equity (2021 - 2025)

Rapid Micro Biosystems' Return on Equity history spans 5 years, with the latest figure at 0.9% for Q3 2025.

  • For Q3 2025, Return on Equity fell 36.0% year-over-year to 0.9%; the TTM value through Sep 2025 reached 0.9%, down 36.0%, while the annual FY2024 figure was 0.49%, 11.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.9% at Rapid Micro Biosystems, down from 0.73% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.34% in Q2 2021 and bottomed at 2.0% in Q3 2021.
  • The 5-year median for Return on Equity is 0.43% (2023), against an average of 0.47%.
  • The largest YoY upside for Return on Equity was 169bps in 2022 against a maximum downside of -68bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.32% in 2021, then fell by -10bps to 0.35% in 2022, then fell by -20bps to 0.43% in 2023, then crashed by -38bps to 0.59% in 2024, then plummeted by -53bps to 0.9% in 2025.
  • Per Business Quant, the three most recent readings for RPID's Return on Equity are 0.9% (Q3 2025), 0.73% (Q2 2025), and 0.64% (Q1 2025).